COMPANY PROFILE

ATAI Life Sciences

Explore full profile

A biotechnology company pioneering mental health innovation

Berlin, GermanyFounded 2018Biotech & Life Sciences

Valuation $2.43B Market cap · Aug/2026

Revenue $4.1M Latest reported FY

At a glance

Status: Listed
Founded: 2018
Headquarters: Berlin, Germany
Listing: IPO 2021
Sector: Biotech & Life Sciences
Power Law: Unicorn$1–10B valuation tier

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

News AmyriAD buys Recognify to expand its cognition drug pipeline Oct 7, 2026

News Eli Lilly to acquire AtaiBeckley for $2.8B to target treatment-resistant depression Jul 16, 2026

Market map Psychedelic therapeutics

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

AGApeiron Investment Group
HCHCS

Series A3 investors entered at this stage

TBThor Bjorgolfsson
MNMike Novogratz
PTPeter Thiel

Series B and later16 investors entered at this stage

WVWhat If Ventures
FVFearless Ventures
WPWoodline Partners
MSMaryanna Saenko
EKEfrem Kamen
HMHighline Capital Management
CMCatalio Capital Management
AGAlpha Wave Global
PIPura Vida Investments
TCThiel Capital
SJSteve Jurvetson
FVFuture Ventures
NVNeo Kuma Ventures
CAChristian Angermayer
SCSubversive Capital
GDGalaxy Investment Partners (Galaxy Digital)

Talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia 4 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former ATAI Life Sciences employees who went on to found companies, sorted by Dealroom signal score.

HEHeadingEst. 2020

ASAli SheikhUnited States

Signal score79

Centenara LabsEst. 2019

Christian AngermayerSwitzerland

Signal score64

ThirdwebEst. 2021

Steven BartlettUnited States

Signal score61

Kanna HealthEst. 2021

Lars Christian WildeUnited Kingdom

Signal score57

Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country

Workforce by country

🇩🇪 Germany · Berlin HQ

Book a demo for the full country breakdown

Web traffic by country

30K monthly visits
across markets

🇲🇽 Mexico22%

🇵🇪 Peru21.3%

🇺🇸 United States19.3%

🇩🇪 Germany11.7%

🇨🇦 Canada9.3%

Top 5 markets shown

Patents

Estimated portfolio value

$12M

77 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where ATAI Life Sciences was the backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

9 deals across ATAI Life Sciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount

By stageCount

By periodCount

Where ATAI Life Sciences deploys vs peers

Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

Compare against